Literature DB >> 15534248

Integrative cortical dysfunction and pervasive motion perception deficit in fragile X syndrome.

C S Kogan1, A Bertone, K Cornish, I Boutet, V M Der Kaloustian, E Andermann, J Faubert, A Chaudhuri.   

Abstract

BACKGROUND: Fragile X syndrome (FXS) is associated with neurologic deficits recently attributed to the magnocellular pathway of the lateral geniculate nucleus.
OBJECTIVE: To test the hypotheses that FXS individuals 1) have a pervasive visual motion perception impairment affecting neocortical circuits in the parietal lobe and 2) have deficits in integrative neocortical mechanisms necessary for perception of complex stimuli.
METHODS: Psychophysical tests of visual motion and form perception defined by either first-order (luminance) or second-order (texture) attributes were used to probe early and later occipito-temporal and occipito-parietal functioning.
RESULTS: When compared to developmental- and age-matched controls, FXS individuals displayed severe impairments in first- and second-order motion perception. This deficit was accompanied by near normal perception for first-order form stimuli but not second-order form stimuli.
CONCLUSIONS: Impaired visual motion processing for first- and second-order stimuli suggests that both early- and later-level neurologic function of the parietal lobe are affected in Fragile X syndrome (FXS). Furthermore, this deficit likely stems from abnormal input from the magnocellular compartment of the lateral geniculate nucleus. Impaired visual form and motion processing for complex visual stimuli with normal processing for simple (i.e., first-order) form stimuli suggests that FXS individuals have normal early form processing accompanied by a generalized impairment in neurologic mechanisms necessary for integrating all early visual input.

Entities:  

Mesh:

Year:  2004        PMID: 15534248     DOI: 10.1212/01.wnl.0000142987.44035.3b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

1.  Resolution of spatial and temporal visual attention in infants with fragile X syndrome.

Authors:  Faraz Farzin; Susan M Rivera; David Whitney
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

2.  Associating neural alterations and genotype in autism and fragile x syndrome: incorporating perceptual phenotypes in causal modeling.

Authors:  Armando Bertone; Julie Hanck; Cary Kogan; Avi Chaudhuri; Kim Cornish
Journal:  J Autism Dev Disord       Date:  2010-12

Review 3.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

4.  Visual evoked potentials and reaction time measurements to motion-reversal luminance- and texture-defined stimuli.

Authors:  Hadi Chakor; Armando Bertone; Michelle McKerral; Jocelyn Faubert; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

Review 5.  Demonstrations of decreased sensitivity to complex motion information not enough to propose an autism-specific neural etiology.

Authors:  Armando Bertone; Jocelyn Faubert
Journal:  J Autism Dev Disord       Date:  2006-01

6.  Global motion perception in 2-year-old children: a method for psychophysical assessment and relationships with clinical measures of visual function.

Authors:  Tzu-Ying Yu; Robert J Jacobs; Nicola S Anstice; Nabin Paudel; Jane E Harding; Benjamin Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-30       Impact factor: 4.799

7.  Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS.

Authors:  Ling M Wong; Naomi J Goodrich-Hunsaker; Yingratana McLennan; Flora Tassone; Melody Zhang; Susan M Rivera; Tony J Simon
Journal:  Neuropsychology       Date:  2014-04-28       Impact factor: 3.295

8.  Altered neural activity of magnitude estimation processing in adults with the fragile X premutation.

Authors:  So-Yeon Kim; Ryu-ichiro Hashimoto; Flora Tassone; Tony J Simon; Susan M Rivera
Journal:  J Psychiatr Res       Date:  2013-09-02       Impact factor: 4.791

9.  Contrast detection in infants with fragile X syndrome.

Authors:  F Farzin; D Whitney; R J Hagerman; S M Rivera
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

10.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.